Originally published In Press as doi:10.1074/jbc.M111883200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22131-22139, June 21, 2002
Lipopolysaccharide-mediated Reactive Oxygen Species and Signal
Transduction in the Regulation of Interleukin-1 Gene Expression*
Hsien-Yeh
Hsu
§ and
Meng-Hsuan
Wen
From the
Faculty of Medical Technology, Institute of
Biotechnology in Medicine, National Yang-Ming University,
112 Taipei, Taiwan
Received for publication, December 13, 2001, and in revised form, March 22, 2002
 |
ABSTRACT |
Lipopolysaccharide (LPS) stimulates
macrophages to release inflammatory cytokines, interleukin-1
(IL-1),
and tumor necrosis factor (TNF). LPS-induced TNF suppresses scavenger
receptor functions in macrophages (van Lenten, B. J., and
Fogelman, A. M. (1992) J. Immunol. 148, 112-116), which is regulated by TNF-mediated protein kinases (Hsu,
H. Y., and Twu, Y. C. (2000) J. Biol. Chem. 275, 41035-41048). To examine the molecular mechanism for LPS induction of IL-1 in macrophages, we demonstrated that LPS quickly stimulated reactive oxygen species (ROS), and 3 h later induced prointerleukin-1
(pro-IL-1, precursor of IL-1) production and IL-1
secretion. LPS stimulated pro-IL-1 message/protein between 3 and
10 h; however, there was a 40% reduction of pro-IL-1 in preincubation of the antioxidant, N-acetylcysteine (NAC).
Moreover, NAC moderated LPS-induced IL-1 secretion partially via
interleukin 1-converting enzyme. The maximal activity of LPS-induced
ERK, JNK, and p38 was 12- (30 min), 5- (30 min), and 16-fold (15 min), respectively. In contrast, NAC reduced ERK activity to 60% and decreased p38 activity to the basal level, but JNK activity was induced
2-fold. Furthermore, the pharmacological antagonists LY294002, SB203580, curcumin, calphostin C, and PD98059 revealed the diverse roles of LPS-mediated protein kinases in pro-IL-1. On the other hand,
NAC and diphenyleneiodonium chloride partially inhibited LPS-induced
Rac activity and protein-tyrosine kinase (PTK), indicating that
LPS-mediated ROS and NADPH oxidase correspond to Rac activation and
IL-1 expression. Our findings establish for the first time that
LPS-mediated PTK/phosphatidylinositol 3-kinase/Rac/p38 pathways play a
more important role than pathways of PTK/PKC/MEK/ERK and of
PTK/phosphatidylinositol 3-kinase/Rac/JNK in the regulation of
pro-IL-1/IL-1. The findings also further elucidate the critical role of
LPS-mediated ROS in signal transduction pathways. Our results suggest
that understanding LPS-transduced signals in IL-1 induction upon the
antibacterial action of macrophages should provide a therapeutic
strategy for aberrant inflammatory responses leading to severe cellular
injury or concurrent multiorgan septic damage.
 |
INTRODUCTION |
Lipopolysaccharide (LPS1
or endotoxin) is a potent activator in the immune system. It induces a
variety of immune responses to severe infection (3-5), such as local
inflammation, antibody production, and septic shock. In addition, LPS
is the major mediator of the high morbidity and mortality rates
characteristic of Gram-negative bacteria, i.e. endotoxic
shock (3, 5). The architecture of LPS consists of three separated
"building blocks" as follows: lipid A, an inner core region, and
the O-specific side chain. These separate building blocks
have widely different compositions and structures that are reflected in
their biological activities (6). In early immune response for LPS,
macrophages, which are the major cellular targets for LPS action, play
a central role in host defense with physical and immune responses
against bacterial infection (4). It is thought that LPS-induced signal
transmission requires binding to specific cellular receptors, including
toll-like receptors (5, 7-9). Whereas bacterial products are binding to toll-like receptors on macrophages, the cells are activated and
stimulate a wide spectrum of host defensive systems. This requires the
activation of multiple signaling molecules in transduction pathways,
for example protein-tyrosine kinase (PTK), LPS receptor-associated serine/threonine kinase, Ras, Raf-1, I
B kinase, MEK,
mitogen-activated protein kinases (MAPKs) (4, 10-16), etc. These
molecules may converge or diverge and often have "cross-talk"
properties, which make signaling networks complicated and with mutual
influence. Subsequently, the signals further transduce to downstream
pathways and activate numerous transcription factors, including AP-1,
NF-
B (13), and ATF-2 (17). This in turn triggers a large amount of
genes encoded for inflammatory mediators and cytokines. These elicited
cytokines are believed to be responsible for cell proliferation, differentiation, immunoregulation, and cytotoxicity for bacteria and
bacterial products (6).
It is known that LPS has multiple and different effects on macrophages,
such as the regulation of macrophage functions (1, 2) and the induction
of inflammatory cytokines such as IL-1, IL-6, and TNF (12, 15, 18, 19).
Although IL-1 is a potent inflammatory cytokine with various biological
activities regulating host defense and immune responses (20), there has
been less investigation of LPS induction of IL-1. In the process of
IL-1 maturation, a precursor molecule referred to as
prointerleukin-1
(pro-IL-1) is produced in the cytosol of
macrophages. Originally, pro-IL-1 is a 31-34-kDa non-active form of
cytokine, until it is cleavaged via an enzymatic procession into a
17-kDa mature functional form by IL-1-converting enzyme (ICE) or
caspase 1 (21-24). After the ICE cleavage, the active IL-1 is released
and exhibits its diverse biological functions.
As growth factors or cytokines, LPS induces MAPKs, including
extracellular signal-regulated kinase (ERK), c-JUN
NH2-terminal protein kinase (JNK), and p38
mitogen-activated protein kinase (p38). These play key roles in the
LPS-mediated signal transduction between extracellular membrane
stimulation and the cytoplasmic response and nuclear activity of the
activation of the gene (11, 17). Specifically, ERK activation involves
cytokine induction and regulation during responses to bacterial
products (25-27). In addition to responding to numerous physiological
and stress stimuli (28-31), JNK is considered to play roles in
regulating the expression of various stress-induced proteins and
inflammatory cytokines (12, 31). p38 is activated in response to stress signals such as LPS, osmotic stress, and pro-inflammatory cytokines (14, 27, 32, 33). Previous studies have shown that the p38 pathway is
critical for LPS-stimulated cytokines release (25, 33), including IL-1
and TNF induction in monocytes (17). Moreover, previous findings (34,
35) indicated that p38 activity could be regulated via Rho GTPase
(Rac1) and PAK.
Reactive oxygen species (ROS) regulate multiple cellular functions such
as DNA synthesis (36), transcription factor activation (37), gene
expression (38), and proliferation (39). The induction of
H2O2 can affect various gene expressions in
macrophages ((40, 41) and this work). There are several indications
that H2O2 may act as a cellular secondary
messenger (37, 42). H2O2 is considered to
activate NF-
B (37), which regulates the expression of multiple
immune and inflammatory molecules. Therefore, for the cell immune
system, H2O2 displays a critical role in the
host defense mechanism. Alternatively, the activation of ROS including H2O2 acts as a significant and adverse
participant in abnormal inflammatory diseases. One of the important
sources of ROS in phagocytes, including macrophage, is NADPH oxidase
activation during phagocytosis (43). NADPH oxidase, which could be
inhibited by diphenyleneiodonium chloride (DPI), is a
membrane-associated complex, which consists of a minimum of four
proteins, i.e. membrane-bound cytochrome
b558, p47phox, p67phox,
and Rac2 in humans or Rac1 in rodents (43). Among these components, Rac
is the most critical for a functional NADPH oxidase whose activity is
regulated by small GTP-binding proteins. In response to phagocytic
stimuli, i.e. lipids, soluble peptides, and opsonized particulates, NADPH oxidase moves electrons from NADPH to reduce O2 to O
. These superoxide free radicals are
rapidly converted to H2O2 and O2 by
cytosolic superoxide dismutase (44, 45) and then sequentially to other
products. Nevertheless, both the mechanism for LPS induction ROS and
the role of induced ROS in cytokine expression of macrophages are still unclear.
To understand how ligation of LPS induces inflammatory cytokine IL-1
gene expression in macrophages, we studied the molecular mechanism for
LPS-mediated signal transduction pathways for various protein kinases
in the regulation of IL-1 gene expression. Here we demonstrate for the
first time that LPS regulation of pro-IL-1/IL-1 expression in
macrophages J774A.1 is partially mediated by NADPH oxidase-derived ROS,
as well as by accompanying the PTK/PI 3-kinase/Rac1/p38 pathway, but
less by the PKC/MEK/ERK pathway and the PTK/PI 3-kinase/Rac1/JNK pathway.
 |
EXPERIMENTAL PROCEDURES |
Cell Cultures
Murine macrophage J774A.1 cell (J774A.1) was obtained from the
ATCC (Manassas, VA), propagated in RPMI 1640 medium supplemented with 10% heated-inactivated fetal bovine serum (HyClone, Logan, UT)
and 2 mM L-glutamine (Invitrogen), and cultured
in 37 °C, 5% CO2 incubator, unless otherwise indicated.
Materials
LPS (from Escherichia coli 0111:B4), sodium
orthovanadate, phenylmethylsulfonyl fluoride, bovine serum albumin
(fraction V), DPI, N-acetylcysteine (NAC), and curcumin were
purchased from Sigma. Calcium Phosphate Transfection® reagent was
purchased from Invitrogen. Immobilon® polyvinylidene difluoride
membrane was obtained from Millipore Inc. (Bedford, MA).
Non-radioactive Western blot Chemiluminescence Reagent, Renaissance®,
was purchased from PerkinElmer Life Sciences. REZOl®C&T
was from PROtech Technology Co. (Taipei, Taiwan). GeneAmp® RNA PCR
kit for RT-PCR amplification was purchased from PerkinElmer Life Sciences.
Growth Factors and Antibodies--
Anti-IL-1
, 3ZD monoclonal
antibody (a gift from the National Institutes of Health, Bethesda, to
Dr. H.-Y. Hsu), anti-rabbit IgG-HRP, anti-mouse IgG-HRP, and protein
A/G plus-agarose were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA); anti-phosphotyrosine, clone 4G10 (mouse monoclonal
IgG2b
), was purchased from Upstate Biotechnology, Inc. (Lake Placid,
NY). The CaspACE® Assay System, Fluorometric, was purchased from
Promega Co. (Madison, WI).
Kinase Assay Kits--
The p44/42 MAPK assay kit,
stress-activated protein kinase/JNK assay kit, and p38 MAPK assay kit
were purchased from Cell Signaling Technology (Beverly, MA). The Rac
activation assay kit was purchased from Upstate Biotechnology, Inc.
(Lake Placid, NY).
Protein Kinase Inhibitors--
PD98059 was from Cell Signaling
Technology; calphostin C and herbimycin A were from
Calbiochem-Novabiochem; LY294002 and SB203580 were from Sigma.
Oligonucleotides--
Primers for pro-IL-1/IL-1 and
glyceraldehyde phosphate dehydrogenase were synthesized from local
MD Bio. Inc. (Taipei, Taiwan). The dominant negative JNK
construct (DN-JNK) was a gift from Dr. Michael Karin (University of
California, San Diego) (46). The dominant negative Rac1 construct
(DN-Rac1) was a gift from Dr. S. Bagrodia (Cornell University, Ithaca,
NY) (47).
Measurement of LPS-induced Intracellular ROS
Intracellular ROS stimulated by LPS was measured by detecting
the fluorescent intensity of either 2',7'-dichlorofluorescein diacetate (DCFH) or the improved analogue carboxyl-DCFH (CM-DCFH) (Molecular Probes, Inc., Eugene, OR) oxidized product, DCF (or CM-DCF),
as described (48). Briefly, 0.5-1.0 × 106 J774A.1
cells/ml grown in serum- and phenol red-free RPMI medium (starvation
medium) for 24 h were preincubated with 2 µmol/liter CM-DCFH and
NAC at 37 °C for 30 min in the dark. To these were added fresh
starvation medium containing LPS for additional incubation at the
indicated times. The relative fluorescent intensity of fluorophore
CM-DCF, which was formed by peroxide oxidation of the non-fluorescent
precursor, was detected at an excitation wavelength of 485 nm and an
emission wavelength of 530 nm with a fluorometer, Cytofluor 2300 (Millipore Inc., Bedford, MA). In contrast, CM-DCFH with starvation
medium was used as a blank control.
Measurement of LPS-induced NO
Cells were seeded in a 1 × 107/100-mm plate
containing 6 ml of media. After 24 h of incubation, the media were
replaced by fetal bovine serum-free medium 1 h prior to LPS
treatment, and the conditioned media were collected at the indicated
times. For assaying NO, 50 µl of conditioned media of each sample was
mixed with 50 µl of Griess reagent I (1% sulfanilamide dissolved in 5% H3PO4) in a 96-well assay plate at room
temperature for 10 min. This was followed by addition of Griess reagent
II (0.1% (w/v) N-1-naphthylethylenediamine) at room
temperature in the dark for another 10 min. The absorbance of reaction
(wavelength at 550 nm) in each well was measured by an MRX microplate
reader (Dynex Tech. Inc., Chantilly, VA). A standard calibration curve for NaNO2 was constructed, and calculation of the relative
absorbance unit for the NO concentration of each sample was as
described (19).
RNA Isolation, RT and PCR Amplification for Detecting the
Expression of Pro-IL-1/IL-1, Analysis of ICE
Activity, Western Blot Analysis, Assay Activity of ERK, JNK, p38, and
Enzyme-linked Immunosorbent Assay (ELISA) for Measurement of IL-1
All methods and procedures followed the previous descriptions
(34).
Measurement of LPS-induced Rac Activity
The measurement of LPS-induced Rac activity followed the
manufacturer's instructions from Upstate Biotechnology, Inc. Briefly, cells were starved for 18 h and then pretreated with or without NAC for 30 min prior to LPS stimulation. The whole cell lysates were
collected at the indicated times and immediately incubated with PAK-1
p21-binding domain agarose (PAK-1 PBD) for immunoprecipitating active PAK-1/Rac-GTP complex. Because the Rac-GTP is able to associate with PAK-1, the amount of activated form of Rac was detected via mouse
monoclonal IgG2b anti-Rac by Western blot analysis.
 |
RESULTS |
LPS-induced ROS in Murine Macrophage J774A.1 Cells--
To
investigate LPS-induced ROS in J774A.1 cells, detection of fluorescent
oxidative product of CM-DCFH was used to examine cell oxygen bursts
(48). As shown in Fig. 1A,
within several minutes LPS (1 µg/ml) stimulation of cells rapidly
induced significant ROS, including more H2O2
production, when compared with that of LPS-untreated control samples,
although there was less, but still significant,
H2O2 generation by low doses of LPS (0.1 µg/ml) (data not shown). In contrast, pretreatment of NAC (10 mM), a potent antioxidant, quickly reduced LPS-induced ROS
release (Fig. 1A) in a dose-dependent fashion
(data not shown). The difference of LPS-induced ROS production in cells
treated with or without NAC continued for the longer testing period of
up to 240 min (Fig. 1B). NAC approximately attenuated 20%
of H2O2 in cells at the steady state (Fig. 1,
A and B). However, we could not totally rule out
the involvement of other ROS including superoxide anion (O
)
(data not shown). Because LPS induces NO (19, 49, 50), a member of the
ROS superfamily which plays multiple biological roles in macrophages,
we extended our examination to measure LPS-induced NO in our system.
The cells were grown at various times in media with or without LPS, and the released NO in conditioned media was measured. In the early stage
of LPS stimulation, there was no detectable NO released from the cells
(Fig. 1C). After incubation of LPS for 7 h, cells gradually produced NO at about 2 µM, and at 24 h the
concentration of NO reached 22 µM. In contrast, in cells
co-incubated with NAC, LPS-induced NO reduced to 0.8 and 6.4 µM at 7 and 24 h, respectively (Fig.
1C).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of NAC on LPS-induced release
of ROS and NO production. To detect release of ROS, J774A.1 cells
were preincubated with CM-DCFH (2 µM) and NAC (10 mM) for 30 min, followed by substitution with medium
containing LPS (1 µg/ml) for additional incubation for the indicated
times. The relative fluorescent intensity of fluorophore CM-DCF was
then detected. The data expressed are one of four representative
experiments. LPS-induced release of ROS over a short period between 0 and 15 min (A); over a long period between 0 and 240 min
(B). C, to detect LPS-induced NO production,
cells (1 × 107/6 ml of medium/100-mm plate) were
stimulated with LPS (0.1 µg/ml), and supernatants were collected
after LPS stimulation at the time indicated and assayed for the NO
concentration by the Griess method. The data are representative of
three similar experiments and expressed as mean ± S.E.
ctr, control.
|
|
LPS Induction and the Role of LPS-induced ROS in Regulation of IL-1
Gene Expression: IL-1 Secretion, Pro-IL-1 Protein Production, and
IL-1/Pro-IL-1 Message Induction as Well as Activation
of ICE--
To detect the effect of LPS on inflammatory cytokine and
IL-1 gene expression by macrophages, we first used ELISA to quantitate mature IL-1 secretion in the conditioned medium of J774A.1 cells. As
shown in Fig. 2A, compared
with untreated control cells, IL-1 secretion increased with a longer
LPS incubation time. For example, at 3 and 24 h, the concentration
of LPS-induced IL-1 was about 5 and 22 pg/ml, respectively. In
contrast, there was less IL-1 released from NAC-pretreated cells,
i.e. 1 (3 h) and 12 pg/ml (24 h), indicating that
LPS-stimulated ROS involves IL-1 secretion.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of LPS-induced ROS on LPS stimulation
of pro-IL-1/IL-1 expression in macrophage J774A.1 cells.
A, time course of LPS-induced IL-1 and inhibitory
effect of NAC on IL-1 secretion. Cells (1 × 107/6 ml
of medium) were stimulated with LPS (0.1 µg/ml), and the supernatants
were collected after stimulation at the time indicated. To analyze the
effect of NAC on LPS-induced IL-1 secretion, cells were incubated with
NAC (10 mM) for 30 min prior to LPS stimulation. Samples
were assayed for the IL-1 content in an IL-1-specific ELISA, as
described under "Experimental Procedures." The experiments were
conducted three times, and all data are expressed as mean ± S.E.
B, time course and the effect of NAC on LPS-induced
pro-IL-1 protein. After cells were stimulated as described above for
the indicated time interval, cell lysates were analyzed by Western
blotting with anti-IL-1 monoclonal antibody at a position of 34 kDa for
pro-IL-1. Pro-IL-1 and -actin (internal control for protein loading)
are indicated as arrows on the right-hand side,
and one of three experiments is presented (n = 3).
C, time course and the effect of NAC on LPS-mediated
pro-IL-1/IL-1 mRNA expression. Total RNA was isolated from treated or untreated J774A.1 cells as indicated. Pro-IL-1
at 563 bp in the ethidium bromide-stained agarose gel was normalized by
comparison to RT-PCR of mRNA of glyceraldehyde phosphate
dehydrogenase (GAPDH), a constitutively expressed gene at
450 bp. Arrows indicate RT-PCR products of pro-IL-1 and
glyceraldehyde phosphate dehydrogenase, respectively. The results shown
are representative of three independent experiments. Quantification of
protein and mRNA expression was carried out by PhosphorImager® of
each sample using ImageQuant® software from Molecular Dynamics, which
is expressed as fold increase relative to the level of cells without
LPS treatment (t = 0, activity of control cells defined
as 1). D, time-dependent activation of
LPS-induced ICE activity in J774A.1 cells. After LPS and NAC
treatments, cell extracts (90 µg of protein) were incubated in the
presence of the fluorescence ICE substrate Ac-YVAD-AMC (50 µM) for 1 h at 30 °C. ICE activity was measured
fluorimetrically after subtracting cleavage with excitation at 360 nm
and emission at 460 nm, as described previously (34). All values shown
are means of triplicate values ± S.E. ctr,
control.
|
|
Next, we investigated whether the increased mature IL-1 was reflected
by induction of a precursor of IL-1, pro-IL-1 protein (molecular
mass of 34 kDa), and IL-1/pro-IL-1 message. A time course study of
LPS-induced pro-IL-1 protein was performed by Western blot assay. For
3-h LPS stimulation, in the absence of NAC, a 21-fold increase of
pro-IL-1 protein was detected as compared with the unstimulated cells,
peaking at 8 h and about 24-fold relative to the control sample.
After 12 h, pro-IL-1 protein decreased, gradually returning to the
basal level at around 18 and 24 h (Fig. 2B). To examine
further the role of LPS-stimulated ROS in pro-IL-1 expression, pro-IL-1
protein was determined by using cells preincubated with NAC followed by
LPS treatment. As shown in Fig. 2B, NAC blockage of
LPS-stimulated ROS decreased LPS-induced pro-IL-1 protein to about 35%
of NAC-free cells between 3 and 12 h. However, after 18 h
there was no difference in pro-IL-1 protein with or without NAC treatment.
Next, by using RT-PCR for 3-h LPS stimulation, pro-IL-1 mRNA
increased more than 30-fold, as compared with untreated cells. Between
8 and 12 h, LPS-induced pro-IL-1 mRNA gradually reduced (Fig.
2C). After 18 h, the increased pro-IL-1 mRNA
returned to the basal level. In contrast, in cells pretreated with NAC,
followed by LPS stimulation between 3 and 8 h, there was generally
about 70 to 40% of pro-IL-1 mRNA, as compared with NAC-free,
LPS-treated samples (Fig. 2C). This indicated that NAC
decreased LPS-induced pro-IL-1 mRNA. A similar regulation of
pro-IL-1 mRNA detected by Northern analyses was compatible to the
message detection by RT-PCR (data not shown).
Post-transcriptional regulation and processing of the pro-IL-1 protein
into a mature IL-1 secretion via ICE has been well reported in various
cells, including macrophages, as in our previous reports (22, 23, 34,
51). Because incubation of macrophages with LPS-induced pro-IL-1
protein simultaneously increased IL-1 secretion in a
time-dependent fashion (Fig. 2, B versus
A), we initially examined whether LPS affects ICE activity
during IL-1 secretion. As shown in Fig. 2D, LPS increased
ICE activity up to 2-fold between 3 and 12 h, peaking at a 4-fold
increase by 18 h, and sequentially returning to the basal level at
24 h, as compared with the control cells. In contrast, there was
no difference in ICE activity in NAC-pretreated cells under LPS
stimulation, as compared with the control cells.
LPS Induces MAPKs Activity as Well as the Effect of LPS-induced ROS
on MAPKs Activity--
To dissect LPS-mediated signal transduction
pathways in the regulation of pro-IL-1 protein and IL-1 secretion, we
systematically dissected LPS-stimulated MAPKs including ERK, JNK, and
p38. Furthermore, we examined the role of LPS-induced ROS in mediating
the activity of MAPKs. Incubation of cells with LPS led to
phosphorylation of Elk-1, a transcriptional factor, indicating LPS
activation of ERK (Fig. 3A).
The experiments for time course of LPS-induced ERK activity were also
conducted. As detected by Western blot analysis with an antibody that
specifically recognized the activated, serine 383-phosphorylated form
of Elk-1 by activated ERK (52), a 4-fold increase in ERK activity was
detected at 15 min, reaching a maximum level of 12-fold at 30 min and
reducing to 6-fold after 60 min (Fig. 3A). In comparison,
there was almost no ERK activity in untreated control cells. To examine
further whether LPS-induced ROS involves LPS mediation of ERK
activation, cells were pretreated with NAC for 30 min prior to LPS
incubation. Upon LPS stimulation, ERK activity in NAC-pretreated cells
increased by 2- (15 min) and 7-fold (30 min), respectively, as compared
with samples without LPS. The relatively lower ERK activity in
NAC-treated cells compared with that of NAC-free cells indicates that
ROS is involved in the LPS-induced ERK activity.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
LPS-induced ROS regulation of multiple MAPKs
activation. J774A.1 cells were treated as described in Fig. 2. The
activated ERK, JNK, and p38 were immunoprecipitated from cell lysates
using specific antibodies. In vitro kinase assays were
performed using the immunoprecipitants as kinases, as described
previously (34). Recombinant Elk-1 fusion protein, c-Jun fusion
protein, and ATF-2 fusion protein were used as substrates for ERK, JNK,
and p38, respectively. LPS-induced ERK (A), JNK
(B), and p38 (C) activities were monitored by
phosphorylation of substrate. These were measured by quantitative
immunoblotting with phospho-Elk-1 (Ser-383) antibody, phospho-c-Jun
(Ser-63) antibody, and phospho-ATF-2 (Thr-71) antibody, respectively.
Comparison and quantitative analysis of LPS-induced ERK, JNK, and p38
activities are represented in histograms (D). The
values shown are the mean ± S.E. of quadruplicate determinations.
All data of relative increased activity are expressed as comparison
with untreated J774A.1 cells, (i.e. t = 0, activity of control cells defined as 1). This is representative of four
such independent experiments.
|
|
The inflammatory stress response of J774A.1 cells to LPS prompted us to
investigate the LPS-mediated JNK signaling pathway. Therefore, we
examined whether LPS activates JNK in the cells. Stimulation of cells
with LPS leads to activation of JNK in a time-dependent
fashion, as determined by Western blot analysis via anti-phospho-c-Jun,
which specifically recognizes the activated serine 63-phosphorylated
form of c-Jun (28, 53, 54). Upon 15-min LPS incubation of cells, JNK
activity gradually increased, with a maximum level of JNK activation at
30 min, about a 5-fold increase over that of untreated cells. Then
after 60 min, it returned to the basal level (Fig. 3B).
Moreover, experiments using NAC to study the effect of ROS on
LPS-mediated JNK activity were conducted. Surprisingly, JNK activity of
NAC-treated cells is super-induced up to 9-fold at both 15 and 30 min,
as compared with the control cells (Fig. 3B). The reason for
induction of higher JNK activity in NAC-treated cells than that of
NAC-free cells (i.e. 9- versus 5-fold) upon LPS
stimulation is unclear and requires further investigation.
To explore additional LPS-mediated signal transduction pathways, we
further examined whether LPS induces p38 activity. This is another
important member of the MAPK superfamily related to inflammatory
responses (32, 33). Upon LPS stimulation, the p38 activity gradually
increased, as detected by Western blot analysis with
anti-phospho-ATF-2, an antibody that specifically recognizes the
activated threonine 71-phosphorylated form of ATF-2 (55) (Fig.
3C). The result of time course study of LPS-induced p38
activity indicated that at around 15 min, the activity of p38 in
LPS-treated cells was ~15 times greater than those of the control
cells and gradually decreased to about 10 and 8 times approximately at
60 and 240 min, respectively (Fig. 3C). In contrast, deprivation of LPS-induced ROS by pretreatment of cells with NAC significantly reduced LPS-stimulated p38 activity to the basal level
after about 30-240 min, as compared with NAC-free cells (Fig.
3C). A quantitative analysis of LPS-induced ERK, JNK, and p38 activity to compare the MAPKs activity with and without NAC is
summarized in Fig. 3D.
The Role of LPS-induced Protein Kinases (PK) in the Regulation of
Pro-IL-1 Protein Expression--
We demonstrated above that LPS
stimulates a battery of MAPK activity, comparable with other recent
reports (15, 26, 27, 32, 33, 56). To elucidate further the role of
various LPS-induced PK-mediated signaling pathways in the regulation of
pro-IL-1 protein expression, we utilized certain specific
pharmacological antagonists such as LY294002, SB203580, curcumin,
calphostin C, and PD98059 that inhibit the activation of PI 3-kinase,
p38, JNK, PKC, and MEK1, respectively. The dose response for specific
PK inhibitors was monitored by directly assaying individual kinase
activity, and the effective working concentrations of PK inhibitors
were determined (data not shown) as reported previously (34). Cells were preincubated with these PK inhibitors for 1 h prior to
stimulation of LPS, and pro-IL-1 protein expression in indicated
samples were analyzed by Western blotting with anti-IL-1 monoclonal
antibody. Pro-IL-1 protein expression was reduced to 15% by LY294002,
to 20% by SB203580, to 50% by curcumin, and to 70% by either
calphostin C or by PD98059, as compared with pro-IL-1 in LPS-stimulated
cells (Fig. 4A).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of protein kinase inhibitors
on LPS-induced pro-IL-1 expression and role of ROS in LPS-induced
pro-IL-1 protein of dominant negative JNK, Rac1, or PI
3-kinase-transfected cells. A, effect of inhibitor
of PKC (calphostin C), of MEK1 (PD98059), of JNK (curcumin), of p38
(SB203580), of PI 3-kinase (LY294002), and NAC on LPS-induced pro-IL-1
expression. This was followed by cells pretreated with calphostin C
(12.64 nM) (sample 2), PD98059 (50 µM) (sample 3), curcumin (10 µM) (sample 4), SB203580 (1 µM) (sample 5), LY294002 (50 µM) (sample 6), for 1 h or NAC
(10 mM) (sample 7) for 30 min. After
this, the pretreated cells were then incubated with LPS (0.1 µg/ml)
for an additional 8 h. After incubation, samples were subjected to
Western blot analysis of pro-IL-1, as described in Fig. 2. The
arrows on the right-hand side represent positions
of pro-IL-1 and -actin (an internal control). This experiment is
representative of three similar experiments. Histograms
represent quantification of pro-IL-1 of each sample. All data of
relative quantity are expressed as comparisons with untreated control
cells (sample 1, and activity of control
cells defined as 1). B, role of ROS in LPS-induced
pro-IL-1 protein of dominant negative JNK, Rac1, or PI
3-kinase-transfected cells. J774A.1 was transiently transfected with
various dominant negative constructs for 24 h, as described
previously (2, 34), and then incubated with NAC prior to LPS
stimulation. Pro-IL-1 protein expression in cells was analyzed with
Western blotting as shown above in A. The values shown are
the mean ± S.E. of triplicate determinations.
|
|
Moreover, experiments for transient transfection of dominant negative
JNK (DN-JNK), dominant negative Rac1 (DN-Rac1), or dominant negative PI
3-kinase (DN-PI3K) into J774A.1 cells were conducted in order to
investigate further the role of PI 3-kinase/Rac in LPS induction of
pro-IL-1. Results of Western blot analyses show that after LPS
stimulation, there was about 30% less pro-IL-1 protein in DN-JNK- or
DN-Rac1-transfected cells than that of control cells, and 40% less
pro-IL-1 protein in DN-PI3K-transfected cells as compared with control
cells (Fig. 4B, sample 2 versus
samples 4, 6, and 8). In
addition, preincubation of NAC in the dominant negative transfectants
synergistically reduced pro-IL-1 expression, except for DN-JNK
transfectant. Specifically, with NAC, there was 30% of the pro-IL-1
protein left in mock cells, and 20% of the pro-IL-1 left in either
DN-Rac1-transfected cells or DN-PI3K-transfected cells, respectively
(Fig. 4B, sample 3 versus
samples 7 and 9). However, there was 50% of the
pro-IL-1 protein left in DN-JNK-transfected cells (Fig. 4B,
sample 3 versus sample 5).
LPS-induced Rac Activity and the Role of ROS in Rac
Activation--
It has been reported (57-59) that LPS induces
Rac/NAPDH oxidase-dependent ROS formation. To investigate
further the potential upstream signaling molecules involving in
LPS-mediated transducing networks, we focused on the activity of a
relevant molecule, Rac1. Upon LPS stimulation, Rac1 activity was
elevated 2.5-3-fold between 5 and 60 min (Fig.
5, samples 2-4
versus 1). In contrast, blocking LPS-induced ROS
via preincubation of NAC consequently reduced Rac1 activity by 40%, as
compared with untreated samples (Fig. 5, samples 2-4
versus samples 6-8). Moreover, DPI, an NADPH
oxidase effective inhibitor (60), significantly reduced LPS-triggered Rac1 activation by 50% as compared with the samples without DPI preincubation (Fig. 5, samples 2-4 versus
samples 10-12).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
The roles of LPS-induced ROS and NADPH
oxidase in differential regulation of LPS-mediated Rac1 activity.
Cells were cultured in the presence or absence of antioxidant
(NAC, 10 mM) or NADPH oxidase inhibitor (DPI, 25 µM), followed by LPS stimulation at the indicated times.
The Rac1-GTP complex was immunoprecipitated from whole cell lysate by
PAK-1 PBD as well as active Rac1. Then the immunoprecipitant was
quantitatively measured, using the anti-Rac antibody as described under
"Experimental Procedures" or in the manufacturer's instructions.
The data of relative Rac1 activity is expressed as compared with
untreated control cells (sample 1, Rac1 activity
is defined as 1). The mean ± S.E. of results from three replicate
determinations and a representative experiment is shown.
|
|
LPS Induces PTP as Well as the Effect of LPS-induced ROS and NADPH
Oxidase on PTP in J774A.1 Cells--
To elucidate the mechanism by
which LPS induces IL-1, the LPS-initiated upstream signal transduction
pathway was examined. For this we examined the LPS stimulation of PTP
via performance of SDS-PAGE and Western blot analysis with monoclonal
anti-phosphotyrosine IgG (61). As shown in Fig.
6, incubation of J774A.1 cells with LPS
induced the appearance of many phosphotyrosyl proteins as compared with
cells incubated with media alone. For example, after a 15-min LPS
stimulation of cells, some apparent tyrosine-phosphorylated proteins of
molecular mass of 38, 42, 44, 52-75, and 100-120 kDa (Fig. 6,
samples 1 versus 2) were observed.
These phosphotyrosyl proteins were identified and specifically
immuno-reacted with anti-p38 IgG, anti-ERK IgG, anti-JNK IgG, anti-Lyn
IgG, and anti-Src IgG, respectively (data not shown). In contrast, NAC
and DPI were utilized to investigate the influence of LPS-induced ROS
and NADPH oxidase in the tyrosine phosphorylation of proteins.
Pretreatment of the cells with either NAC or DPI for 30 min prior to
LPS stimulation resulted in a decrease of LPS-induced tyrosine
phosphorylation of various proteins (Fig. 6, sample 2 versus samples 4 and 6), indicating
the involvement of ROS in LPS-induced PTP.

View larger version (105K):
[in this window]
[in a new window]
|
Fig. 6.
LPS stimulation of protein tyrosine
phosphorylation in J774A.1 cells. Cells were pretreated with NAC
(10 mM) or DPI (25 µM) for 30 min prior to
stimulation with or without LPS (1 µg/ml). Briefly, Sample
1, un-stimulated control; sample 2,
LPS 15 min; sample 3, NAC 30 min;
sample 4, NAC 30 min sequentially with LPS 15 min; sample 5, DPI 30 min; sample
6, DPI 30 min sequentially with LPS 15 min. Cells were lysed
and analyzed by Western blot with anti-phosphotyrosine monoclonal
antibody. The detailed method was as described previously (61). The
indicated bars on the left-hand side represent
molecular mass (kDa), and those on the right-hand side
represent some significant molecules, as discussed in text. The
experiment is representative of three similar experiments.
|
|
 |
DISCUSSION |
LPS, a potent activator for macrophages, stimulates ROS such as
H2O2 (see Ref. 40 and this work), superoxides
(see Ref. 62 and data not shown) and NO (see Ref. 49 and this work) as
well as inducing a battery of signal transductions leading to gene
expression (10-16, 26, 63). However, the relationship among
LPS-induced ROS and mediated various PK activation and regulation of
the inflammatory cytokine IL-1 is unclear. Here we analyze and define
the molecular mechanisms for LPS-stimulated ROS production, signal
transductions, and PK activity in regulation of IL-1 expression.
By using the CM-DCFH fluorescent method, we demonstrate that LPS
immediately induced H2O2 in J774A.1 cells but
that pretreatment of cells with NAC effectively inhibited LPS-induced
H2O2 elevation. We also report here that LPS
induced detectable NO production, which was obviously much later than
both pro-IL-1/IL-1 induction (7 versus 3 h, Figs. 1 and
2) and MAPKs activation (7 versus 1 h, Figs. 1 and 3),
although NO is an important reactive oxygen molecule mediating response
of LPS in macrophages (49). Our current findings suggest that
LPS-induced ROS, rather than NO, play a more significant role in the
activation of MAPKs and regulation of pro-IL-1/IL-1 in our system (see
below). However, we could not totally rule out the effects of NO or
cross-talk among NO and other ROS in these reactions.
Initially, the data from studies of ICE activity, ELISA, Western blot
analysis, and RT-PCR showed that LPS-triggered
H2O2 played an important role in the induction
of IL-1 gene. To investigate further the molecular mechanism for ROS
effects, we found evidence that ROS participated in IL-1/pro-IL-1
expression involving multiple levels of regulation. Specifically, in
the presence or absence of antioxidant NAC, our results indicate
LPS-induced ROS regulation of IL-1 expression, probably at pro-IL-1
message (transcriptional), at pro-IL-1 protein production
(translational), and at the processing of pro-IL-1 to mature IL-1
releasing via modification of ICE activity (post-translational). In
addition to the antioxidation of NAC involving the elevation of
intracellular glutathione levels (38, 40, 64, 65), NAC is able to block
the activation of JNK in response to TNF (2) or interferon
co-stimulation with TNF in macrophages (66). Nevertheless, the
mechanism for NAC reduction of LPS-induced ICE activity related to IL-1
secretion requires further study.
LPS stimulation of MAPKs (ERK, JNK, and p38) activity and activation of
transcription factors (AP-1, NF-
B, and ATF-2) have been reported
previously (25, 26, 67-69). In addition, activation of MEK/ERK and p38
critical for LPS-induced cytokine production by monocytes/macrophages
has been documented (25, 26, 33). However, there is little discussion
of the molecular mechanism for LPS-mediated MAPKs in the regulation and
expression of pro-IL-1/IL-1. We demonstrate for the first time that
there were differences in the activation time and in extent of activity
for LPS-stimulated ERK, JNK, and p38. Moreover, the effect of
LPS-induced ROS on the activity of specific MAPK was also diverse (Fig.
3). For example, NAC blockage of LPS-induced ROS resulted in a decrease
in ERK and p38 activity but an increase in JNK activity as compared
with untreated cells. We summarize the effect of LPS-induced ROS on the
relative activity of LPS-induced MAPKs (Fig. 3D), which
indicates that the existence of ROS was more effective and important to p38 activity than either ERK or JNK activity in LPS-mediated regulation of pro-IL-1/IL-1 expression. Nevertheless, when all of the three MAPK
pathways were activated simultaneously, a dramatic induction of IL-1
gene expression was observed, suggesting a cooperative effect on
regulation of IL-1 among these kinases (15). We further used various
pharmacological antagonists to PKs. It dissected the specific role of
individual PK in the regulation of pro-IL-1 expression (Fig.
4A). Additional studies of the use of dominant PK negative
transfectants verified that both NAC and specific dominant negative PK
synergistically reduced LPS-induced pro-IL-1 protein expression (Fig.
4B). Although stimulation of a single PK produced only a
modest effect on pro-IL-1 protein, activation of each PK pathway was
important for complete induction of IL-1 gene expression.
Various studies have shown the activation of JNK and p38 were mediated
via PI 3-kinase/Rac1/PAK signaling pathway (2, 47, 70). Rac1 is
important to LPS-induced pro-IL-1 in at least two aspects as follows:
first the role of Rac1 in NADPH oxidase assemble/function (71), and
second its role in PI 3-kinase/Rac1/PAK signaling pathway. Rac is known
as an important component of functional NADPH oxidase, which is
localized at the plasma membrane or specific granule vesicle membrane
of phagocytes, and which produces O
upon phagocytosis
processing (71). Because of the DPI reduction of LPS-triggered Rac1
activation (Fig. 5B), our data imply that LPS
activates phagocytosis-related NADPH oxidase, which interacts with
Rac1, leading signals as the initial of ROS (Fig.
7). Moreover, data on transient
transfection of DN-Rac1 indicates partially reduced LPS-mediated
pro-IL-1 expression. Although preincubation of NAC led to additional
decreasing of pro-IL-1 (Fig. 4B), indicating the importance
of Rac1 and/or NADPH oxidase and ROS in LPS-induced pro-IL-1. Our
finding of NADPH oxidase and Rac1 involving ROS production is
consistent with the recent report (58) of Rac1-dependent ROS in LPS-mediated TNF secretion. Indeed, our current results clearly demonstrate that the originality of LPS-induced ROS including H2O2 as a secondary messenger is mainly derived
from NADPH oxidase and less from LPS-damaged mitochondria in the short
term (data not shown) or via other molecule(s), which mediate signal
transductions and regulate pro-IL-1 protein and IL-1 secretion.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
The proposed model for LPS-mediated ROS and
signal transduction pathways in the regulation of pro-IL-1/IL-1
expression.
|
|
Ligation of LPS quickly induces diverse phosphotyrosyl proteins,
leading to activation of various downstream molecules (27), although
there is no evidence that the receptors including toll-like receptors
have a functional tyrosine kinase domain. Because alteration of PTP is
one of the most important signaling events leading to cellular
responses (6), and to further understand how LPS is coupled to the
initiation of early signaling by inducing various PTP resulting in
up-regulation of IL-1 gene expression, we initially examined and
identified the LPS-induced protein tyrosine phosphorylation, including
MAPKs (ERK, JNK, and p38) and the Src family (Src and Lyn).
Furthermore, we investigated LPS ligation, showing the relationships among LPS-induced ROS and NADPH oxidase and observed alteration of PTP.
The results of antioxidant of ROS (NAC) or NADPH oxidase inhibitor
(DPI) reducing LPS-induced tyrosine kinase activation suggest that ROS
indeed involves LPS-induced protein tyrosine phosphorylation.
In summary, we are the first to demonstrate that in macrophages the
relationship among NADPH oxidase-derived ROS, protein tyrosine
phosphorylation, and the role of ROS in the regulation of IL-1 gene
expression during LPS stimulation. Our results dissect the molecular
mechanism of LPS-induced ROS regulation of pro-IL-1 protein and IL-1
secretion. This regulation is at multiple levels and involves
LPS-mediated PTK, PK, and MAPK activity. Although LPS-mediated
cooperation of multiple MAPKs induces IL-1 gene expression, we show for
the first time that the LPS-induced PTK/Rac1/PI 3-kinase/p38 pathway
plays a relatively more important role than the pathways of
PTK/PKC/MEK/ERK and of PTK/Rac1/PI 3-kinase/JNK in the specific cytokine regulation (Fig. 7). Thus, understanding how LPS-mediated signal transduction pathways in IL-1 induction is responsible for
macrophage antibacterial action may provide improved treatments for
severe inflammatory responses leading to cellular injury, multiorgan
damage, and concurrent sepsis.
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge the DN-JNK
construct from Dr. M. Karin (University of California, San Diego),
DN-Rac1 construct from Dr. S. Bagrodia (Cornell University, Ithaca,
NY), and the anti-IL-1
, 3ZD monoclonal antibody from the National
Institutes of Health (Bethesda).
 |
FOOTNOTES |
*
This work was supported by Research Grants NSC
90-2321-B-010-005 (to H.-Y. H.) from the National Science Council,
Taiwan, NHRI-EX90-8937SL (to H.-Y. H.) from the National Health
Research Institutes, Taiwan, and A-91-B-FA09-2-4 (to H.-Y. H.) Program for Promoting Academic Excellence of Universities from the Ministry of
Education, Taiwan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom reprint requests and correspondence should be addressed:
Faculty of Medical Technology, Institute of Biotechnology in Medicine,
National Yang-Ming University, 155 Li-Nong St., Shih-Pai, Taipei,
Taiwan. Tel.: 11-886-2-2826-7252; Fax: 11-886-2-2826-4092, E-mail:
hyhsu@ym.edu.tw.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M111883200
 |
ABBREVIATIONS |
The abbreviations used are:
LPS, lipopolysaccharide;
ROS, reactive oxygen species;
IL-1, interleukin-1
;
pro-IL-1, prointerleukin-1
;
NAC, N-acetyl-cysteine;
DPI, diphenyleneiodonium chloride;
MAPK, mitogen-activated protein kinase;
ERK, extracellular signal-regulated
kinase;
JNK, c-JUN NH2-terminal protein kinase;
p38, p38
mitogen activated protein kinase;
PI 3-kinase, phosphatidylinositol
3-kinase;
PAK, p21-activated kinase;
PTK, protein-tyrosine kinase;
PTP, protein tyrosine phosphorylation;
ICE, interleukin 1-converting enzyme;
TNF, tumor necrosis factor;
CM-DCFH, carboxyl-2',7'-dichlorofluorescein
diacetate;
DN, dominant negative;
ELISA, enzyme-Linked immunosorbent
assay;
PK, protein kinases;
PKC, protein kinase C;
RT, reverse
transcriptase.
 |
REFERENCES |
| 1.
|
Van Lenten, B. J.,
and Fogelman, A. M.
(1992)
J. Immunol.
148,
112-116[Abstract]
|
| 2.
|
Hsu, H. Y.,
and Twu, Y. C.
(2000)
J. Biol. Chem.
275,
41035-41048[Abstract/Free Full Text]
|
| 3.
|
Mikuni, Y.,
Matsuguchi, T.,
Takano, M.,
Nishimura, H.,
Washizu, J.,
Ogawa, T.,
Takeuchi, O.,
Akira, S.,
Nimura, Y.,
and Yoshikai, Y.
(2000)
J. Immunol.
165,
931-940[Abstract/Free Full Text]
|
| 4.
|
Weinstein, S. L.,
Gold, M. R.,
and DeFranco, A. L.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4148-4152[Abstract/Free Full Text]
|
| 5.
|
Fenton, M. J.,
and Golenbock, D. T.
(1998)
J. Leukocyte Biol.
64,
25-32[Abstract]
|
| 6.
|
Henderson, B.,
Poole, S.,
and Wilson, M.
(1996)
Microbiol. Rev.
60,
316-341[Abstract/Free Full Text]
|
| 7.
|
Lin, Y.,
Lee, H.,
Berg, A. H.,
Lisanti, M. P.,
Shapiro, L.,
and Scherer, P. E.
(2000)
J. Biol. Chem.
275,
24255-24263[Abstract/Free Full Text]
|
| 8.
|
Beutler, B.
(2002)
Curr. Opin. Hematol.
9,
2-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Yang, H.,
Young, D. W.,
Gusovsky, F.,
and Chow, J. C.
(2000)
J. Biol. Chem.
275,
20861-20866[Abstract/Free Full Text]
|
| 10.
|
Ulevitch, R. J.,
and Tobias, P. S.
(1995)
Annu. Rev. Immunol.
13,
437-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Geppert, T. D.,
Whitehurst, C. E.,
Thompson, P.,
and Beutler, B.
(1994)
Mol. Med.
1,
93-103[Medline]
[Order article via Infotrieve]
|
| 12.
|
Reimann, T.,
Buscher, D.,
Hipskind, R. A.,
Krautwald, S.,
Lohmann-Matthes, M. L.,
and Baccarini, M.
(1994)
J. Immunol.
153,
5740-5749[Abstract]
|
| 13.
|
Shakhov, A. N.,
Collart, M. A.,
Vassalli, P.,
Nedospasov, S. A.,
and Jongeneel, C. V.
(1990)
J. Exp. Med.
171,
35-47[Abstract/Free Full Text]
|
| 14.
|
Geng, Y.,
Valbracht, J.,
and Lotz, M.
(1996)
J. Clin. Invest.
98,
2425-2430[Medline]
[Order article via Infotrieve]
|
| 15.
|
Zhu, W.,
Downey, J. S., Gu, J., Di,
Padova, F.,
Gram, H.,
and Han, J.
(2000)
J. Immunol.
164,
6349-6358[Abstract/Free Full Text]
|
| 16.
|
Sweet, M. J.,
and Hume, D. A.
(1996)
J. Leukocyte Biol.
60,
8-26[Abstract]
|
| 17.
|
Gray, J. G.,
Chandra, G.,
Clay, W. C.,
Stinnett, S. W.,
Haneline, S. A.,
Lorenz, J. J.,
Patel, I. R.,
Wisely, G. B.,
Furdon, P. J.,
and Taylor, J. D.
(1993)
Mol. Cell. Biol.
13,
6678-6689[Abstract/Free Full Text]
|
| 18.
|
Loppnow, H.,
and Libby, P.
(1990)
J. Clin. Invest.
85,
731-738[Medline]
[Order article via Infotrieve]
|
| 19.
|
Xaus, J.,
Comalada, M.,
Valledor, A. F.,
Lloberas, J.,
Lopez-Soriano, F.,
Argiles, J. M.,
Bogdan, C.,
and Celada, A.
(2000)
Blood
95,
3823-3831[Abstract/Free Full Text]
|
| 20.
|
Loppnow, H.,
Werdan, K.,
Reuter, G.,
and Flad, H. D.
(1998)
Eur. Cytokine Netw.
9,
675-680[Medline]
[Order article via Infotrieve]
|
| 21.
|
Schumann, R. R.,
Belka, C.,
Reuter, D.,
Lamping, N.,
Kirschning, C. J.,
Weber, J. R.,
and Pfeil, D.
(1998)
Blood
91,
577-584[Abstract/Free Full Text]
|
| 22.
|
Cerretti, D. P.,
Kozlosky, C. J.,
Mosley, B.,
Nelson, N.,
Van Ness, K.,
Greenstreet, T. A.,
March, C. J.,
Kronheim, S. R.,
Druck, T.,
and Cannizzaro, L. A.
(1992)
Science
256,
97-100[Abstract/Free Full Text]
|
| 23.
|
Thornberry, N. A.,
Bull, H. G.,
Calaycay, J. R.,
Chapman, K. T.,
Howard, A. D.,
Kostura, M. J.,
Miller, D. K.,
Molineaux, S. M.,
Weidner, J. R.,
and Aunins, J.
(1992)
Nature
356,
768-774[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Dinarello, C. A.
(1997)
Cytokine Growth Factor Rev.
8,
253-265[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Carter, A. B.,
Monick, M. M.,
and Hunninghake, G. W.
(1999)
Am. J. Respir. Cell Mol. Biol.
20,
751-758[Abstract/Free Full Text]
|
| 26.
|
Scherle, P. A.,
Jones, E. A.,
Favata, M. F.,
Daulerio, A. J.,
Covington, M. B.,
Nurnberg, S. A.,
Magolda, R. L.,
and Tracks, J. M.
(1998)
J. Immunol.
161,
5681-5686[Abstract/Free Full Text]
|
| 27.
|
Raingeaud, J.,
Gupta, S.,
Rogers, J. S.,
Dickens, M.,
Han, J.,
Ulevitch, R. J.,
and Davis, R. J.
(1995)
J. Biol. Chem.
270,
7420-7426[Abstract/Free Full Text]
|
| 28.
|
Pombo, C. M.,
Bonventre, J. V.,
Avruch, J.,
Woodgett, J. R.,
Kyriakis, J. M.,
and Force, T.
(1994)
J. Biol. Chem.
269,
26546-26551[Abstract/Free Full Text]
|
| 29.
|
Devary, Y.,
Gottlieb, R. A.,
Lau, L. F.,
and Karin, M.
(1991)
Mol. Cell. Biol.
11,
2804-2811[Abstract/Free Full Text]
|
| 30.
|
Binetruy, B.,
Smeal, T.,
and Karin, M.
(1991)
Nature
351,
122-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Hambleton, J.,
Weinstein, S. L.,
Lem, L.,
and DeFranco, A. L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2774-2778[Abstract/Free Full Text]
|
| 32.
|
Han, J.,
Lee, J. D.,
Bibbs, L.,
and Ulevitch, R. J.
(1994)
Science
265,
808-811[Abstract/Free Full Text]
|
| 33.
|
Lee, J. C.,
Laydon, J. T.,
McDonnell, P. C.,
Gallagher, T. F.,
Kumar, S.,
Green, D.,
McNulty, D.,
Blumenthal, M. J.,
Heys, J. R.,
and Landvatter, S. W.
(1994)
Nature
372,
739-746[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Hsu, H. Y.,
Chiu, S. L.,
Wen, M. H.,
Chen, K. Y.,
and Hua, K. F.
(2001)
J. Biol. Chem.
276,
28719-28730[Abstract/Free Full Text]
|
| 35.
|
Zhang, S.,
Han, J.,
Sells, M. A.,
Chernoff, J.,
Knaus, U. G.,
Ulevitch, R. J.,
and Bokoch, G. M.
(1995)
J. Biol. Chem.
270,
23934-23936[Abstract/Free Full Text]
|
| 36.
|
Crawford, D.,
Zbinden, I.,
Moret, R.,
and Cerutti, P.
(1988)
Cancer Res.
48,
2132-2134[Abstract/Free Full Text]
|
| 37.
|
Schreck, R.,
Rieber, P.,
and Baeuerle, P. A.
(1991)
EMBO J.
10,
2247-2258[Medline]
[Order article via Infotrieve]
|
| 38.
|
Lo, Y. Y.,
and Cruz, T. F.
(1995)
J. Biol. Chem.
270,
11727-11730[Abstract/Free Full Text]
|
| 39.
|
Murrell, G. A.,
Francis, M. J.,
and Bromley, L.
(1990)
Biochem. J.
265,
659-665[Medline]
[Order article via Infotrieve]
|
| 40.
|
Hong, Y. H.,
Peng, H. B., La, F., V,
and Liao, J. K.
(1997)
J. Immunol.
159,
2418-2423[Abstract/Free Full Text]
|
| 41.
|
Kaul, N.,
Gopalakrishna, R.,
Gundimeda, U.,
Choi, J.,
and Forman, H. J.
(1998)
Arch. Biochem. Biophys.
350,
79-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Fialkow, L.,
Chan, C. K.,
Rotin, D.,
Grinstein, S.,
and Downey, G. P.
(1994)
J. Biol. Chem.
269,
31234-31242[Abstract/Free Full Text]
|
| 43.
|
Bokoch, G. M.
(1995)
Trends Cell Biol.
5,
109-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Finkel, T.
(1999)
J. Leukocyte Biol.
65,
337-340[Abstract]
|
| 45.
|
Hanukoglu, I.,
Rapoport, R.,
Weiner, L.,
and Sklan, D.
(1993)
Arch. Biochem. Biophys.
305,
489-498[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Li, Y. S.,
Shyy, J. Y., Li, S.,
Lee, J., Su, B.,
Karin, M.,
and Chien, S.
(1996)
Mol. Cell. Biol.
16,
5947-5954[Abstract]
|
| 47.
|
Bagrodia, S.,
Derijard, B.,
Davis, R. J.,
and Cerione, R. A.
(1995)
J. Biol. Chem.
270,
27995-27998[Abstract/Free Full Text]
|
| 48.
|
Wan, C. P.,
Myung, E.,
and Lau, B. H.
(1993)
J. Immunol. Methods
159,
131-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Park, L. C.,
Zhang, H.,
Sheu, K. F.,
Calingasan, N. Y.,
Kristal, B. S.,
Lindsay, J. G.,
and Gibson, G. E.
(1999)
J. Neurochem.
72,
1948-1958[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Matsuno, R.,
Aramaki, Y.,
Arima, H.,
and Tsuchiya, S.
(1997)
Biochem. Biophys. Res. Commun.
237,
601-605[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Ghayur, T.,
Banerjee, S.,
Hugunin, M.,
Butler, D.,
Herzog, L.,
Carter, A.,
Quintal, L.,
Sekut, L.,
Talanian, R.,
Paskind, M.,
Wong, W.,
Kamen, R.,
Tracey, D.,
and Allen, H.
(1997)
Nature
386,
619-623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Marais, R.,
Wynne, J.,
and Treisman, R.
(1993)
Cell
73,
381-393[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Minden, A.,
Lin, A.,
Smeal, T.,
Derijard, B.,
Cobb, M.,
Davis, R.,
and Karin, M.
(1994)
Mol. Cell. Biol.
14,
6683-6688[Abstract/Free Full Text]
|
| 54.
|
Kyriakis, J. M.,
Banerjee, P.,
Nikolakaki, E.,
Dai, T.,
Rubie, E. A.,
Ahmad, M. F.,
Avruch, J.,
and Woodgett, J. R.
(1994)
Nature
369,
156-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Livingstone, C.,
Patel, G.,
and Jones, N.
(1995)
EMBO J.
14,
1785-1797[Medline]
[Order article via Infotrieve]
|
| 56.
|
Han, J.,
Jiang, Y., Li, Z.,
Kravchenko, V. V.,
and Ulevitch, R. J.
(1997)
Nature
386,
296-299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Karlsson, A.,
Markfjall, M.,
Stromberg, N.,
and Dahlgren, C.
(1995)
Infect. Immun.
63,
4606-4612[Abstract]
|
| 58.
|
Sanlioglu, S.,
Williams, C. M.,
Samavati, L.,
Butler, N. S.,
Wang, G.,
McCray, P. B. J.,
Ritchie, T. C.,
Hunninghake, G. W.,
Zandi, E.,
and Engelhardt, J. F.
(2001)
J. Biol. Chem.
276,
30188-30198[Abstract/Free Full Text]
|
| 59.
|
Koay, M. A.,
Christman, J. W.,
Segal, B. H.,
Venkatakrishnan, A.,
Blackwell, T. R.,
Holland, S. M.,
and Blackwell, T. S.
(2001)
Infect. Immun.
69,
5991-5996[Abstract/Free Full Text]
|
| 60.
|
O'Donnell, B. V.,
Tew, D. G.,
Jones, O. T.,
and England, P. J.
(1993)
Biochem. J.
290,
41-49[Medline]
[Order article via Infotrieve]
|
| 61.
|
Hsu, H. Y.,
Hajjar, D. P.,
Khan, K. M.,
and Falcone, D. J.
(1998)
J. Biol. Chem.
273,
1240-1246[Abstract/Free Full Text]
|
| 62.
|
Wong, G. H.,
and Goeddel, D. V.
(1988)
Science
242,
941-944[Abstract/Free Full Text]
|
| 63.
|
Schletter, J.,
H |